Evidence map›Paper›PMID 36794853›Full record

ArticleNucleic acids research2023

PARP1 associates with R-loops to promote their resolution and genome stability.

Natalie Laspata, Parminder Kaur, Sofiane Yacine Mersaoui, Daniela Muoio, Zhiyan Silvia Liu, Maxwell Henry Bannister, Hai Dang Nguyen, Caroline Curry, John M Pascal, Guy G Poirier and 3 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
19.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. BCLXSignal transduction and targeted therapy · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 2 countries.

Natalie LaspataUPMC Hillman Cancer Center, University of Pittsburgh Cancer Institute, Department of Pharmacology and Chemical Biology, Pittsburgh, PA 15213, USA.
Parminder KaurPhysics Department, Raleigh, NC 27695, USA.
Sofiane Yacine MersaouiCHU de Québec Research Centre, HDQ Pavilion, Oncology Division, Laval University Cancer Research Center, McMahon, Québec City, Québec G1R 3S3, Canada.
Daniela MuoioUPMC Hillman Cancer Center, University of Pittsburgh Cancer Institute, Department of Pharmacology and Chemical Biology, Pittsburgh, PA 15213, USA.
Zhiyan Silvia LiuDepartment of Pharmacology, The Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.ORCID 0000-0001-5902-9375
Maxwell Henry BannisterDepartment of Pharmacology, The Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Hai Dang NguyenDepartment of Pharmacology, The Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Caroline CurryDepartment of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
John M PascalDepartment of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, Québec H3C 3J7, Canada.
Guy G PoirierDepartment of Molecular Biology, Medical Biochemistry and Pathology, Université Laval, Quebec, Canada.
Hong WangPhysics Department, Raleigh, NC 27695, USA.
Jean-Yves MassonCHU de Québec Research Centre, HDQ Pavilion, Oncology Division, Laval University Cancer Research Center, McMahon, Québec City, Québec G1R 3S3, Canada.ORCID 0000-0002-4403-7169
Elise FouquerelUPMC Hillman Cancer Center, University of Pittsburgh Cancer Institute, Department of Pharmacology and Chemical Biology, Pittsburgh, PA 15213, USA.ORCID 0000-0002-2542-2563
University of Minnesota · USThomas Jefferson University · USUniversité Laval · CAUPMC Hillman Cancer Center · USCentre hospitalier universitaire de Québec · CANorth Carolina State University · USUniversité de Montréal · CA

Funding

University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
Institutional Career Development CoreKL2TR002492 · NCATS · UNIVERSITY OF MINNESOTA · PI INGBAR, DAVID H · 2018 to 2022
$6.3M
Implications of PARP1 in myelodysplastic syndromes and targeted therapyR01HL163011 · NHLBI · UNIVERSITY OF MINNESOTA · PI Dang Hai Nguyen · 2022 to 2026
$2.5M
Sequence and Structure Specific DNA Binding by Cohesin and Genome StabilityR01GM123246 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI WANG, HONG · 2018 to 2021
$1.2M
Deciphering the mechanisms of PARP1 activity in telomere integrityR00ES027028 · NIEHS · THOMAS JEFFERSON UNIVERSITY · PI FOUQUEREL, ELISE · 2019 to 2021
$747k
NCATS NIH HHS KL2 TR002492NCATS NIH HHS UL1 TR002494NHLBI NIH HHS R01 HL163011NIEHS NIH HHS R00 ES027028NIGMS NIH HHS R01 GM123246
6 · The paper itself

Abstract

PARP1 is a DNA-dependent ADP-Ribose transferase with ADP-ribosylation activity that is triggered by DNA breaks and non-B DNA structures to mediate their resolution. PARP1 was also recently identified as a component of the R-loop-associated protein-protein interaction network, suggesting a potential role for PARP1 in resolving this structure. R-loops are three-stranded nucleic acid structures that consist of a RNA-DNA hybrid and a displaced non-template DNA strand. R-loops are involved in crucial physiological processes but can also be a source of genome instability if persistently unresolved. In this study, we demonstrate that PARP1 binds R-loops in vitro and associates with R-loop formation sites in cells which activates its ADP-ribosylation activity. Conversely, PARP1 inhibition or genetic depletion causes an accumulation of unresolved R-loops which promotes genomic instability. Our study reveals that PARP1 is a novel sensor for R-loops and highlights that PARP1 is a suppressor of R-loop-associated genomic instability.

Indexed as

Genomic InstabilityPoly (ADP-Ribose) Polymerase-1R-Loop StructuresDNADNA RepairHumansRNADNAPARP1 protein, humanPoly (ADP-Ribose) Polymerase-1RNA

Identifiers

PMID36794853
PMCPMC10018367
OpenAlexW4321004823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.